Skip Navigation
Skip to contents
Filter

PUBLICATION DATE

3 results
Display

Risk of graft loss on once-daily versus twice-daily tacrolimus in kidney transplant patients: a meta-analysis

Kandarini Y, Mahadita GW, Widiana IGR, Paramita Ayu N

Background: Tacrolimus has been used as immunosuppressant for various organ transplantation, including kidney. Recently, clinician is more interested in using once-daily tacrolimus compared to twice-daily due to higher adherence. One...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The comparison of coefficient of variation among once-daily and twice-daily tacrolimus in kidney transplant patients: a meta-analysis

Mahadita GW, Widiana IGR, Kandarini Y

Background: Kidney transplantation is the treatment of choice end stage renal disease. Tacrolimus often used as prophylaxis of organ rejection in patients receiving organ transplants. Maintaining tacrolimus trough levels is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Health technology assessment of kidney transplantation and hemodialysis for the treatment of end-stage kidney disease

Mahadita GW, Widiana IGR, H. Marbun MB, Ayu NP, Kandarini Y, Mahendra IBN, Pratiwi Duarsa RS, Putra IMR

Background: Kidney transplantation is an expensive procedure, and it is an alternative treatment of end-stage renal disease other than dialysis. Cost-effectiveness and the cost-utility study was undertaken at Prof. Dr....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr